Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01694563 · ClinicalTrials.gov registry record · NA
ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation
A NA study, sponsored by AtriCure.
- Completed
- Registry status
- NA
- Development phase
- 365
- Enrollment target
NCT01694563 is a NA study that has completed, run by AtriCure. The registered enrollment target is 365 participants.
The verdict
NCT01694563, a NA study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- NA
- Development phase
- 365 participants
- Enrollment target
Study Summary
The primary objective of this post-approval study is to evaluate the clinical outcomes in a cohort of patients with non-paroxysmal forms of atrial fibrillation (persistent or long-standing persistent) treated during commercial use of the AtriCure Synergy Ablation System by physicians performed the Maze IV procedure.
Interventions
- DEVICE Synergy Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2012-09 |
| Est. Completion | 2018-03-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01694563
The ClinicalTrials.gov registry entry for NCT01694563 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 365 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Synergy Ablation System is the first listed.
NCT01694563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01694563 about?
NCT01694563 is a clinical study titled "ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation". The primary objective of this post-approval study is to evaluate the clinical outcomes in a cohort of patients with non-paroxysmal forms of atrial fibrillation (persistent or long-standing persistent) treated during commercial use of the AtriCure Synergy Ablation System by physicians performed the M...
What is the current status of trial NCT01694563?
This trial is currently completed. It is a NA study. The enrollment target is 365 participants. The study started on 2012-09. Estimated completion is 2018-03-21.
What interventions are being tested in trial NCT01694563?
The interventions under investigation include: Synergy Ablation System (DEVICE).
Who is sponsoring clinical trial NCT01694563?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.